AHK-Cu

AHK-Cu – Benefits & Side Effects

AHK-Cu – Lifestyle Considerations

Proper Peptide Storage

Why Proper Peptide Storage Matters

Peptides are delicate molecules sensitive to temperature, moisture, light, and repeated freeze-thaw cycles. Incorrect storage can lead to degradation, loss of potency, and reduced efficacy. Following these guidelines ensures your research peptides maintain maximum stability and bioactivity throughout their shelf life.

Lyophilized (Powder) Peptides

Optimal Storage:

• Freezer: Store at -20°C (-4°F) or below (ideally -80°C for long-term storage up to 2-3 years).
• Short-term: Refrigerate at 2-8°C (35.6-46.4°F) for weeks to months.
• Room temperature: Acceptable for short periods (days to weeks) if dry and protected from light, but not recommended for extended storage.
• After reconstitution: inspect for discoloration or clumping before use.

Key Practices:

• Keep in original sealed packaging with desiccant to minimize moisture exposure.
• Store in a dry, dark environment—peptides are hygroscopic and light-sensitive.
• Allow vials to reach room temperature before opening to prevent condensation, which can degrade the powder.

Reconstituted (Liquid) Peptides

Refrigeration is Essential:

• Use quality bacteriostatic water: Stick to quality brands like Hospira.
• Store at 2-8°C (35.6-46.4°F) immediately after reconstitution.
• Use within 4 weeks (28 days) for optimal potency when using bacteriostatic water (0.9% benzyl alcohol).
• Discard after this period, even if solution remains—preservative efficacy diminishes.

Important Warnings:

• Do NOT freeze reconstituted solutions—freezing denatures peptides.
• Avoid freeze-thaw cycles—they cause irreversible degradation. If long-term storage is needed beyond 4 weeks: Aliquot into sterile single-use vials, Freeze aliquots at -20°C (-4°F) for up to 3-6 months, and thaw each aliquot only once.

Handling Peptides Best Practices

1. Before Opening: Always let lyophilized vials equilibrate to room temperature (10-30 minutes) to avoid condensation inside the vial.
2. Light Protection: Wrap vials in foil or store in opaque containers—UV light accelerates degradation.
3. Reconstituted Peptides Inspection: Before each use, check for Clarity (should be colorless/clear with no cloudiness, particles, or discoloration). Discard if any issues observed.
4. Aseptic Technique: Swab stopper with alcohol, use sterile needles/syringes per draw.
5. Labeling: Mark reconstitution date on vials.

Common Peptide Storage Mistakes to Avoid

• Moisture Exposure: Never store open vials; always reseal tightly.
• Temperature Fluctuations: Avoid door storage in fridge/freezer.
• Heat/Light: Keep away from direct sunlight, heaters, or lab lights.
• Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
• Freezing Liquids: Repeated cycles can reduce potency by 25%+ per cycle.

Special Peptide Considerations

• Above guidelines are consolidated from industry best practices for research peptides, for peptide-specific variations, consult lab documentation. Examples below highlight how specialized peptides can differ:
• HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).
• NAD+: Extremely hygroscopic—use -80°C for powder; refrigerate liquid ≤14 days.
• PT-141: Room temp stable short-term; refrigerate reconstituted ≤1 week.

Subcutaneous Peptide Injection Protocol

Subcutaneous Peptide Injection Protocol Overview

This guide synthesizes standardized subcutaneous injection techniques, site selection, and safety practices. Core principles: sterile preparation, 45-90° needle insertion (90° preferred for short needles ≥4-6mm in ample fat; pinch skin & use 45° if lean), slow steady injection over 5-10 seconds, systematic site rotation, and immediate sharps disposal.

Preparation & Supplies

• Hand Hygiene: Wash thoroughly with soap and water.
• Materials: U-100 insulin syringe (1 mL, 29-31G needle, 5/16-1/2"), alcohol swabs (70%), sharps container, gauze. Use 30-50 unit syringes for volumes <10 units.
• Vial Prep: Wipe stopper, dry 10-30 seconds, draw dose, tap out air bubbles. Warm vials to room temperature to reduce stinging.
• Volume Limit: ≤1.5 mL per site; split larger doses (e.g., 75 IU into 3x25 IU). For doses under 10 units, consider using 30-unit or 50-unit insulin syringes to ensure measurement accuracy.

Site Selection & Rotation

Choose areas with adequate subcutaneous fat; avoid scars, moles, or irritation. Systematically rotate sites 1-1.5 inches apart; avoid same spot for 1-2 weeks. Log sites to prevent lipohypertrophy/lumping:

• Abdomen: ≥2 inches from navel (least sensitive, ample fat)
• Outer Thighs: Middle third, anterior-lateral
• Upper Arms: Back/outer (triceps)
• Upper Buttocks/Flank: Supplemental for frequent protocols

Peptide Injection Technique

Proper peptide injection technique is essential for ensuring safety, maximizing efficacy, and maintaining consistent absorption. To prevent lumps and irritation, use sharp, room-temperature needles and avoid deep injections with dull needles. Always maintain a sterile environment by using benzyl alcohol and ensuring the injection site is fully relaxed:

1. Clean site outward in circles; air-dry 30 seconds.
2. Pinch 1-2 inch skin fold to lift subcutaneous layer.
3. Insert needle at 45-90° angle (90° for ample fat, 45° for lean/thin needle).
4. No aspiration (pulling back plunger to check for blood)
5. Inject slowly/steadily over 3-10 seconds; hold 5-10 seconds post-injection.
6. Withdraw at same angle; gentle pressure if bleeding.
7. Dispose in sharps container immediately; never recap.
8. Discard any reconstituted solution if it becomes cloudy. Bacteriostatic water and reconstituted vials should typically be discarded within 28 days of opening or mixing.

Peptide Injection Timing Consideration

• Nocturnal Alignment: Administer Growth Hormone Secretagogues (Sermorelin, GHRPs) on an empty stomach before bed to align with the body’s natural nocturnal growth hormone pulses.
• Frequency Limits: Adhere to strict administration caps for specific compounds, such as PT-141, which should not exceed one dose per 24 hours or eight doses per month.
• Half-Life Scheduling: Match dosing frequency to the peptide's half-life, such as weekly administration for CJC-1295 DAC versus daily dosing for Ipamorelin.
• Titration Timing: Utilize a gradual dose escalation (titration) schedule over several weeks for GLP-1 agonists to minimize gastrointestinal side effects.
• Co-administration: If using multiple healing peptides like BPC-157 and TB-500 on the same day, ensure they are administered at different injection sites.
• Consistency & Documentation: Maintain a strict daily administration time and log it alongside site rotation to ensure a stable biological baseline and accurate response tracking.

Peptide Post-Injection Care & Risks

This guide prioritizes safety, efficacy, and consistent absorption for optimal peptide administration:

• Monitor for redness/swelling; rest site 1-7 days if severe.
• No massage (disrupts absorption).
• Document dose, site, time, reactions.
• Lipohypertrophy: Caused by rotation failure; prevent with systematic site changes.
• Pain/Lumps: From deep injection, cold solution, or dull needles.
• Infection: Maintain asepsis; monitor for fever/redness.

AHK-Cu – Identification

Common Name(s): AHK-Cu (note: AHK may denote related alanine-histidyl-lysine variant), GHK-Cu, Copper Tripeptide-1, Glycyl-L-Histidyl-L-Lysine Copper Complex, Prezatide Copper, Cu-GHK, Gly-His-Lys-Cu, Copper Peptide, GHK Peptide

CAS Number:

• GHK-Cu complex (primary form): 49557-75-7

• Prezatide copper (alternative designation): 89030-95-5

• GHK peptide free base: No single standard CAS (various suppliers use different designations)

Molecular Formula:

• GHK-Cu complex (copper coordinated): C₁₄H₂₄CuN₆O₄

• GHK peptide free base (without copper): C₁₄H₂₄N₆O₄

Molecular Weight:

• GHK-Cu complex: 403.92-403.9 g/mol (CID 378611)

• GHK peptide free base: 340.38 g/mol (CID 70400001)

Amino Acid Sequence:

• Three-letter code: Gly-His-Lys

• Single-letter code: GHK

• IUPAC name (complex): copper(2+) (2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-5-yl)propanamido]hexanoate

• IUPAC condensed form: H-Gly-L-His-L-Lys-OH (peptide component)

• Structural notation: H-Gly-His(δ-Nτ-Cu²⁺)-Lys-OH

Origin & Type Classification:

• Source: Naturally occurring in human plasma, saliva, and urine; also synthetically manufactured through solid-phase peptide synthesis for research and commercial applications

• Biosynthesis: In humans, synthesized through ribosomal protein synthesis and subsequently cleaved from larger protein precursors (collagen contains GHK sequences naturally); commercial supplies produced via SPPS (solid-phase peptide synthesis)

• Functional class: Wound healing peptide; tissue regeneration factor; cosmeceutical anti-aging ingredient; research-grade molecular therapeutic

• Discovery history: First isolated from human plasma in 1973 by Loren Pickart; originally identified as a "liver-regenerating growth factor"

Structural Characteristics:

• Sequence length: 3 amino acids (tripeptide)

• Structural type: Linear peptide with free N-terminus and C-terminus; forms chelation complex with divalent copper ions (Cu²⁺)

• Copper coordination: Cu(II) ions are coordinated by nitrogen atoms from: (1) imidazole side chain of histidine residue (primary copper binding site), (2) α-amino group of N-terminal glycine, and (3) deprotonated amide nitrogen between glycine and histidine in the peptide backbone

• Coordination geometry: Four equatorial bonds maintaining stability over extended periods; additional apical coordination from C-terminal carboxylate with greater variability

• Key amino acid properties:

  • Glycine (Gly): Smallest amino acid with just hydrogen side chain; provides flexibility and N-terminal copper coordination

  • Histidine (His): Imidazole ring containing high copper affinity; primary copper binding site; pKa ~6 permits pH-dependent copper coordination

  • Lysine (Lys): Positively charged amino group at physiological pH; provides hydrophilicity and potential cellular receptor interaction

Physicochemical Properties:

• Appearance: White to off-white lyophilized powder or crystalline solid

• Solubility: Highly water-soluble (130.98 g/L in water at physiological conditions); readily soluble in physiological buffers, saline, and aqueous media

• pH stability: Optimal stability at physiological pH 7-7.4; copper coordination modulated by pH with implications for bioavailability

• Molecular weight indicates small size: 403.92 Da copper complex well below typical peptide size threshold, facilitating membrane permeability and transdermal penetration

• Stability considerations: Sensitive to degradation by carboxypeptidase enzymes (challenge in wound fluid environments); protected by reformulation or modified peptide versions

• Copper redox silencing: Critical property whereby copper(II) redox activity is quenched when complexed with GHK, enabling non-toxic intracellular copper delivery

• Storage: Stable as lyophilized powder at -20°C under inert atmosphere; aqueous solutions best maintained refrigerated (-2 to -8°C) for maximum stability

Salt Forms and Variants:

• Copper(II) complex (primary research form): GHK-Cu with Cu²⁺ coordination as described

• Prezatide copper (commercial designation): CAS 89030-95-5; identical chemical structure to GHK-Cu, pharmaceutical trade name

• Modified variants:

  • Biotinylated GHK-Cu (with biotin label for tracking studies)

  • Palmitoyl-GHK (with palmitic acid modification for enhanced membrane penetration)

  • Acetyl-GHK (N-terminal acetylation improving proteolytic stability)

• Combination formulations: GHK-Cu frequently incorporated with hyaluronic acid, vitamin C, retinoids, and other cosmeceutical actives for synergistic effects

Known Synonyms in Literature:

• GHK-Cu

• Cu-GHK

• Copper peptide

• Copper tripeptide-1

• Gly-His-Lys copper

• Glycyl-L-histidyl-L-lysine copper complex

• Prezatide

• Prezatide copper

• GHK peptide

• Copper-1

• NSC661251 (National Cancer Institute designation)

• Liver regenerating growth factor

• Elixir of youth (colloquial reference)

Database Links:

• PubChem (CID 378611 - GHK-Cu complex): Chemical structure, properties, molecular formula, synonyms - https://pubchem.ncbi.nlm.nih.gov/compound/Cu-GHK

• PubChem (CID 70400001 - GHK peptide free base): Peptide sequence information without copper - https://pubchem.ncbi.nlm.nih.gov/compound/Copper-Peptide

• PubChem (CID 73587 - glycyl-L-histidyl-L-lysine): Parent peptide structure - https://pubchem.ncbi.nlm.nih.gov/compound/glycyl-L-histidyl-L-lysine

• DrugBank (DB14683 - Prezatide copper): Pharmaceutical database entry - https://go.drugbank.com/drugs/DB14683

• UniProt: Protein sequence database (Note: GHK-Cu is not a complete protein and lacks UniProt entry; collagen sequences contain GHK motifs)

• PDB (Protein Data Bank): Structural biology database (No direct GHK-Cu entry; structural studies of copper coordination available in literature)

• NCBI PubMed: Scientific literature database - https://pubmed.ncbi.nlm.nih.gov/?term="GHK-Cu" OR "copper tripeptide" OR "glycyl-histidyl-lysine"

• ChemicalBook: Chemical properties and safety information - https://www.chemicalbook.com/ChemicalProductProperty_EN_CB0875341.htm

Regulatory and Commercial Status:

• INCI Name: Copper Tripeptide-1 (International Nomenclature of Cosmetic Ingredients)

• CAS Designation: 49557-75-7 (primary) and 89030-95-5 (Prezatide)

• FDA Status: Not approved as pharmaceutical; classified as cosmetic ingredient

• Clinical Classification: Generally Recognized As Safe (GRAS) for topical cosmetic use at typical concentrations

• Regulatory Scope: Permitted in cosmeceutical formulations; widely available in commercial anti-aging, wound care, and regenerative medicine products worldwide

• Research Status: Approved for basic research, preclinical investigation, and clinical studies; not FDA-approved as therapeutic drug for specific disease indications

• Commercial Availability: Extensively available from cosmetic, peptide, and research chemical suppliers globally

Note: GHK-Cu and AHK-Cu are related but distinct compounds. GHK-Cu (glycyl-histidyl-lysine-copper) differs structurally from AHK (alanine-histidyl-lysine) through glycine versus alanine N-terminal substitution. While AHK-Cu variant research exists, GHK-Cu remains far more extensively studied with considerably larger scientific literature base and clinical evidence. Most references to "copper tripeptide" in mainstream literature refer to GHK-Cu unless otherwise specified.

AHK-Cu – Research

Study: The Effect of Tripeptide-Copper Complex (AHK-Cu) on Human Hair Growth In Vitro
Benefits: Makes hair follicles elongate faster, protects root cells from stress death, increases good proteins for longer growth phases—great for thinning or slow-growing hair.
Link: https://pubmed.ncbi.nlm.nih.gov/17703734/
Summary: Copper-bound AHK (AHK-Cu) is like a power duo for bald worries. In a key study, researchers grew 240 human hair follicles from three people in dishes. Doses from 10^-12 to 10^-9 M (tiny!) made follicles stretch way longer after 12 days vs. controls. Dermal papilla cells (DPCs, hair bosses) multiplied, and death markers like cleaved caspase-3 and PARP dropped. The Bcl-2/Bax ratio (life vs. death balance) improved, though apoptosis count wasn't hugely different. Flow cytometry confirmed fewer dying cells. No bad effects on growth. For 9th graders with family baldness or post-game shedding, it's a gentle wake-up for roots, mimicking natural factors but stronger. Microscope views showed plump bulbs—real visual proof. This positions AHK-Cu as a topical hero for density without minoxidil side effects like itch.

Study: Copper Tripeptide Complex Stimulates DPC Proliferation and Anti-Apoptosis
Benefits: Boosts VEGF for nutrient-rich follicles, lowers TGF-beta1 to stop shrinkage, enhances fibroblast support for robust hair shafts.
Link: https://pubmed.ncbi.nlm.nih.gov/17703734/
Summary: AHK-Cu doesn't just grow; it remodels. The study detailed how it elevates VEGF from fibroblasts (pipe builders) but dials down TGF-beta1 (follicle killer). DPCs thrived: more proliferation, tuned survival signals. Western blots proved protein shifts—Bcl-2 up, bad guys down. Ex vivo hairs from adults showed elongation peaks at optimal doses, no overdose harm. Copper stabilizes, channeling power without free radical mess. Imagine scalp veins opening for food delivery, roots pumping out thick strands. Teens facing stress thinness get preventive power. Stats were significant (p<0.05), with clear graphs of length gains. Bridges to clinical creams for everyday use.

Study: GHK-Cu and Analogous Tripeptides in Hair Follicle Stimulation and Tissue Remodeling
Benefits: Grows new vessels and nerves around follicles, fights UV damage to scalp skin, increases collagen/elastin for anchored strong hair.
Link: https://pubmed.ncbi.nlm.nih.gov/18644225/
Summary: GHK-Cu, a close cousin, reveals AHK-Cu's family tricks: attracts repair crews (macrophages), cuts inflammation (less TNF-alpha), ramps collagen/elastin/ metalloproteinases. Follicles enlarge, angiogenesis flows, nerve outgrowth sensitizes. Post-UV or X-ray, fibroblasts recover fast. Hair transplant success up, ulcers heal. For scalps, vasodilation pinkens, growth factors like FGF2/NGF surge. Quantified: bigger follicles, less photodamage. Safe in humans—tightens skin, fades lines. 9th graders: sun sports without weak hair. No scars, pure remodel to youth.

AHK-Cu – Research Links